Search research articles
Contact Us
Filters
Showing results (81-90 of 152) with videos related to
Page
of 16
Sort By:
American Journal of Clinical Oncology
|
May 22, 2018
A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer
Emerson Y Chen, Charles D Blanke, Daniel G Haller, et al.
Annals of Surgical Oncology
|
January 9, 2023
Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)
Sepideh Gholami, Sarah Colby, David P Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 7, 2005
Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials
Joseph M Unger, Charles A Coltman, John J Crowley, et al.
Clinical Colorectal Cancer
|
July 26, 2011
Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions
David Z J Chu, Michael A Hussey, David S Alberts, et al.
Clinical Colorectal Cancer
|
December 14, 2017
Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713
Cynthia Gail Leichman, Shannon L McDonough, Stephen R Smalley, et al.
Journal of the National Cancer Institute
|
August 30, 2024
Plant-based diet and survival among patients with metastatic colorectal cancer
En Cheng, Fang-Shu Ou, Clare Gatten, et al.
Cancer Epidemiology
|
June 25, 2018
The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials
Joseph M Unger, William E Barlow, Catherine M Tangen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT
Charles D Blanke, George D Demetri, Margaret von Mehren, et al.
Archives of Pathology & Laboratory Medicine
|
February 4, 2010
Protocol for the examination of specimens from patients with gastrointestinal stromal tumor
Brian P Rubin, Charles D Blanke, George D Demetri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma
Lawrence P Leichman, Bryan H Goldman, Pierre O Bohanes, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 152) with videos related to
Sort By:
Page
of 16
American Journal of Clinical Oncology
|
May 22, 2018
A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer
Emerson Y Chen, Charles D Blanke, Daniel G Haller, et al.
Annals of Surgical Oncology
|
January 9, 2023
Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)
Sepideh Gholami, Sarah Colby, David P Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 7, 2005
Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials
Joseph M Unger, Charles A Coltman, John J Crowley, et al.
Clinical Colorectal Cancer
|
July 26, 2011
Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions
David Z J Chu, Michael A Hussey, David S Alberts, et al.
Clinical Colorectal Cancer
|
December 14, 2017
Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713
Cynthia Gail Leichman, Shannon L McDonough, Stephen R Smalley, et al.
Journal of the National Cancer Institute
|
August 30, 2024
Plant-based diet and survival among patients with metastatic colorectal cancer
En Cheng, Fang-Shu Ou, Clare Gatten, et al.
Cancer Epidemiology
|
June 25, 2018
The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials
Joseph M Unger, William E Barlow, Catherine M Tangen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT
Charles D Blanke, George D Demetri, Margaret von Mehren, et al.
Archives of Pathology & Laboratory Medicine
|
February 4, 2010
Protocol for the examination of specimens from patients with gastrointestinal stromal tumor
Brian P Rubin, Charles D Blanke, George D Demetri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma
Lawrence P Leichman, Bryan H Goldman, Pierre O Bohanes, et al.
Page
of 16